News & AnalysisTranscenta lands $105mTranscenta, a global biotherapeutics company, has raised $105 million in financing.ByIris Dorbian23 December 2020•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs